Alcohol use disorder tied to development of chronic kidney disease: A nationwide database analysis

被引:35
|
作者
Pan, Chi-syuan [1 ]
Ju, Teressa Reanne [2 ]
Lee, Chi Chan [3 ]
Chen, Yu-Pei [4 ]
Hsu, Chung-Y [4 ]
Hung, Dong-Zong [1 ]
Chen, Wei-Kung [1 ]
Wang, I-Kuan [5 ,6 ]
机构
[1] China Med Univ Hosp, Dept Emergency Med, Taichung, Taiwan
[2] Mackay Mem Hosp, Taipei, Taiwan
[3] Oregon Hlth Sci Univ Hosp, Dept Crit Care, Portland, OR USA
[4] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan
[5] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan
[6] China Med Univ Hosp, Dept Nephrol, Taichung, Taiwan
来源
PLOS ONE | 2018年 / 13卷 / 09期
关键词
SERUM CYSTATIN-C; ESTIMATED GFR; CONSUMPTION; POPULATION; RISK; ASSOCIATION; CREATININE; MARKER; IDENTIFICATION; METAANALYSIS;
D O I
10.1371/journal.pone.0203410
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction Alcohol use disorder (AUD) is a spectrum of high risk behaviors including alcohol abuse and dependence. Chronic kidney disease (CKD) is progressive loss of renal function for more or equal to 3 months or presence of any irreversible kidney damage. Common risk factors of CKD have been identified, but the impact of alcohol consumption on kidney function is controversial. The study aims to investigate the relationship between alcohol use disorder and CKD on a national scale. Methods This retrospective cohort study was conducted using Taiwan's National Health Insurance research database. Patients aged 20 years or older, without CKD and with the diagnosis of AUD (ICD-9-CM codes 303.X; 305.0, V113) from years 2000 to 2013 were enrolled. Control cohort was selected to match the demographics of the target population. Patients were followed until the end of 2013 or earlier if they developed CKD, died, or lost follow up. Baseline characteristics and comorbidities were identified for risk stratification. Results We identified 11639 patients in the AUD cohort and 46556 patients in the control cohort. Compared to patients in the control cohort, those in the AUD group were more likely to have multiple comorbidities (p < 0.001 for all comorbidities). After adjustment of age, gender, baseline comorbidities, and nonsteroidal anti-inflammatory drug use, the diagnosis of AUD was associated with an increased risk of CKD development (aHR = 1.62, 95% CI, 1.46-1.81). During the mean follow up periods of 6.47 (standard deviation (SD) = 3.80) years for the AUD cohort and 7.23 (SD = 3.75) years for the control cohort, the overall incidence density of CKD was significantly higher in patients with AUD than those in the control cohort (3.48 vs 6.51 per 1000 person-years, aHR = 1.68, 95% CI, 1.50-1.87). Kaplan-Meier analysis showed that the AUD cohort had a higher cumulative incidence of CKD than the control cohort (log-rank test, p value < 0.001). Patients with AUD had higher risks of CKD in all the stratified groups, except for the subgroup with age over 65 years old. Conclusion Our study suggested that AUD was associated with an increased incidence of newly diagnosed CKD by nearly two folds. Young age, in particular, had a higher association between AUD and CKD. Considering the preventable nature of AUD, establishing effective health policies is imperative to reduce high-risk alcohol behaviors and thereby prevent alcohol related kidney disease. Further prospective studies are warranted to further elucidate the causation of AUD on kidney function.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Improvement of kidney function in patients with chronic kidney disease and severe obesity after bariatric surgery: A systematic review and meta-analysis
    Lee, Yung
    Anvari, Sama
    Chu, Megan M.
    Lovrics, Olivia
    Khondker, Adree
    Malhan, Roshan
    Aditya, Ishan
    Doumouras, Aristithes G.
    Walsh, Michael
    Hong, Dennis
    NEPHROLOGY, 2022, 27 (01) : 44 - 56
  • [32] Clinical features of patients with chronic liver disease in Japan related to alcohol use: Nationwide examination using alcohol use disorders identification test
    Hiraoka, Atsushi
    Nakai, Masato
    Hara, Nagisa
    Hanai, Tatsunori
    Namisaki, Tadashi
    Miyaaki, Hisamitsu
    Nakahara, Takashi
    Hiramatsu, Akira
    Ohama, Hideko
    Tada, Fujimasa
    Takahashi, Hirokazu
    Aikata, Hiroshi
    Eguchi, Yuichiro
    Hiasa, Yoichi
    Yoshiji, Hitoshi
    HEPATOLOGY RESEARCH, 2023, 53 (01) : 43 - 50
  • [33] Caffeine consumption and mortality in chronic kidney disease: a nationally representative analysis
    Vieira, Miguel Bigotte
    Magrico, Rita
    Dias, Catarina Viegas
    Leitao, Lia
    Neves, Joao Sergio
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (06) : 974 - 980
  • [34] Meta-analysis of traditional Chinese medicine on chronic kidney disease
    Wang, Xian-Ya
    Zhao, Shu-Hua
    Wang, An-Na
    Zou, Di
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2024, 24 (03) : 353 - 359
  • [35] Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver Disease A Systematic Review
    Crowley, Matthew J.
    Diamantidis, Clarissa J.
    McDuffie, Jennifer R.
    Cameron, C. Blake
    Stanifer, John W.
    Mock, Clare K.
    Wang, Xianwei
    Tang, Shuang
    Nagi, Avishek
    Kosinski, Andrzej S.
    Williams, John W., Jr.
    ANNALS OF INTERNAL MEDICINE, 2017, 166 (03) : 191 - +
  • [36] Retinal vein occlusion and chronic kidney disease: A meta-analysis
    Fang, Li Jian
    Dong, Li
    Li, Yi Fan
    Wei, Wen Bin
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2021, 31 (04) : 1945 - 1952
  • [37] Genome-wide meta-analysis of alcohol use disorder in East Asians
    Zhou, Hang
    Kalayasiri, Rasmon
    Sun, Yan
    Nunez, Yaira Z.
    Deng, Hong-Wen
    Chen, Xiang-Ding
    Justice, Amy C.
    Kranzler, Henry R.
    Chang, Suhua
    Lu, Lin
    Shi, Jie
    Sanichwankul, Kittipong
    Mutirangura, Apiwat
    Malison, Robert T.
    Gelernter, Joel
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (10) : 1791 - 1797
  • [38] Weighing the evidence for treatment of chronic kidney disease mineral and bone disorder
    Navaneethan, Sankar D.
    Palmer, Suetonia C.
    Schreiber, Martin J.
    Strippoli, Giovanni F. M.
    NEPHROLOGY, 2009, 14 (04) : 363 - 366
  • [39] Phenotypes of Mineral Bone Disorder in Chronic Kidney Disease in a Dialysis Population
    Rojas-Campos, Enrique
    Ruvalcaba-Contreras, Neri
    Campos-Mariz, Alejandro
    Aguilar-Campos, Arantxa
    Andrade-Sierra, Jorge
    Ignacio Cerrillos-Gutierrez, Jose
    Medina-Perez, Miguel
    Evangelista-Carrillo, Luis
    Banda, Adriana
    Cueto-Manzano, Alfonso M.
    ARCHIVES OF MEDICAL RESEARCH, 2024, 55 (04)
  • [40] Subclinical thyroid dysfunction and chronic kidney disease: a nationwide population-based study
    Kim, Hye Jeong
    Park, Sang Joon
    Park, Hyeong Kyu
    Byun, Dong Won
    Suh, Kyoil
    Yoo, Myung Hi
    BMC NEPHROLOGY, 2023, 24 (01)